Thymidine Catabolism as a Metabolic Strategy for Cancer Survival

Cell Reports

Volumn 19, Issue 7, 2017, Pages 1313-1321

  Tabata, Sho ^a   Yamamoto, Masatatsu ^b   Goto, Hisatsugu ^c   Hirayama, Akiyoshi ^a   Ohishi, Maki ^a   Kuramoto, Takuya ^c   Mitsuhashi, Atsushi ^c   Ikeda, Ryuji ^b   Haraguchi, Misako ^b   Kawahara, Kohichi ^b   Shinsato, Yoshinari ^b   Minami, Kentaro ^b   Saijo, Atsuro ^c   Hanibuchi, Masaki ^c   Nishioka, Yasuhiko ^c   Sone, Saburo ^c   Esumi, Hiroyasu ^d   Tomita, Masaru ^a   Soga, Tomoyoshi ^a   Furukawa, Tatsuhiko ^b   Akiyama, Shin ichi ^e   more..

^a KEIO UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

^e NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

2 deoxy D ribose; glycolysis; thymidine; thymidine catabolism; thymidine phosphorylase

Indexed keywords

GLUCOSE 6 PHOSPHATE; LACTIC ACID; PHOSPHORIBOSYL PYROPHOSPHATE; SERINE; THYMIDINE; THYMIDINE PHOSPHORYLASE; CARBON; DEOXYRIBOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CARBON SOURCE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEIC ACID METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; METABOLISM; NUTRITIONAL STATUS; PATHOLOGY; PHOSPHORYLATION; STOMACH TUMOR; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ANIMALS; CARBON; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYRIBOSE; GLYCOLYSIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; NUTRITIONAL STATUS; PHOSPHORYLATION; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; THYMIDINE; THYMIDINE PHOSPHORYLASE;

EID: 85019195391     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.04.061     Document Type: Article

References (37)

1. Accorsi, A., Piatti, E., Piacentini, M.P., Gini, S., Fazi, A., Isoenzymes of phosphoglucomutase from human red blood cells: isolation and kinetic properties. Prep. Biochem. 19 (1989), 251–271.
2. Akiyama, S., Furukawa, T., Sumizawa, T., Takebayashi, Y., Nakajima, Y., Shimaoka, S., Haraguchi, M., The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression. Cancer Sci. 95 (2004), 851–857.
3. Allen, E., Miéville, P., Warren, C.M., Saghafinia, S., Li, L., Peng, M.W., Hanahan, D., Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling. Cell Rep. 15 (2016), 1144–1160.
4. Bijnsdorp, I.V., Azijli, K., Jansen, E.E., Wamelink, M.M., Jakobs, C., Struys, E.A., Fukushima, M., Kruyt, F.A., Peters, G.J., Accumulation of thymidine-derived sugars in thymidine phosphorylase overexpressing cells. Biochem. Pharmacol. 80 (2010), 786–792.
5. Brown, N.S., Jones, A., Fujiyama, C., Harris, A.L., Bicknell, R., Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res. 60 (2000), 6298–6302.
6. Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M., Akiyama, S., Fukui, K., Ishizawa, M., Yamada, Y., Angiogenic factor. Nature, 356, 1992, 668.
7. Gatenby, R.A., Smallbone, K., Maini, P.K., Rose, F., Averill, J., Nagle, R.B., Worrall, L., Gillies, R.J., Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br. J. Cancer 97 (2007), 646–653.
8. Griffiths, L., Dachs, G.U., Bicknell, R., Harris, A.L., Stratford, I.J., The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res. 57 (1997), 570–572.
9. Haraguchi, M., Miyadera, K., Uemura, K., Sumizawa, T., Furukawa, T., Yamada, K., Akiyama, S., Yamada, Y., Angiogenic activity of enzymes. Nature, 368, 1994, 198.
10. Haraguchi, M., Tsujimoto, H., Fukushima, M., Higuchi, I., Kuribayashi, H., Utsumi, H., Nakayama, A., Hashizume, Y., Hirato, J., Yoshida, H., et al. Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice. Mol. Cell. Biol. 22 (2002), 5212–5221.
11. Hirano, M., Garone, C., Quinzii, C.M., CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders. Biochim. Biophys. Acta 1820 (2012), 625–631.
12. Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M., et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69 (2009), 4918–4925.
13. Hoffee, P.A., 2-deoxyribose gene-enzyme complex in Salmonella typhimurium. I. Isolation and enzymatic characterization of 2-deoxyribose-negative mutants. J. Bacteriol. 95 (1968), 449–457.
14. Hotchkiss, K.A., Ashton, A.W., Schwartz, E.L., Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3. J. Biol. Chem. 278 (2003), 19272–19279.
15. Jiménez-Valerio, G., Martínez-Lozano, M., Bassani, N., Vidal, A., Ochoa-de-Olza, M., Suárez, C., García-Del-Muro, X., Carles, J., Viñals, F., Graupera, M., et al. Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients. Cell Rep. 15 (2016), 1134–1143.
16. Lu, H., Klein, R.S., Schwartz, E.L., Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap. Clin. Cancer Res. 15 (2009), 5136–5144.
17. Matsushita, S., Nitanda, T., Furukawa, T., Sumizawa, T., Tani, A., Nishimoto, K., Akiba, S., Miyadera, K., Fukushima, M., Yamada, Y., et al. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res. 59 (1999), 1911–1916.
18. Mayer, R.J., Van Cutsem, E., Falcone, A., Yoshino, T., Garcia-Carbonero, R., Mizunuma, N., Yamazaki, K., Shimada, Y., Tabernero, J., Komatsu, Y., et al., RECOURSE Study Group. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N. Engl. J. Med. 372 (2015), 1909–1919.
19. Miyadera, K., Sumizawa, T., Haraguchi, M., Yoshida, H., Konstanty, W., Yamada, Y., Akiyama, S., Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res. 55 (1995), 1687–1690.
20. Nakajima, Y., Gotanda, T., Uchimiya, H., Furukawa, T., Haraguchi, M., Ikeda, R., Sumizawa, T., Yoshida, H., Akiyama, S., Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose. Cancer Res. 64 (2004), 1794–1801.
21. Nishida, Y., Miyamoto, T., Properties and activities of phosphoribomutase in the human leukemic cells. Int. J. Biochem. 14 (1982), 961–963.
22. Nishino, I., Spinazzola, A., Hirano, M., Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283 (1999), 689–692.
23. Pisarsky, L., Bill, R., Fagiani, E., Dimeloe, S., Goosen, R.W., Hagmann, J., Hess, C., Christofori, G., Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy. Cell Rep. 15 (2016), 1161–1174.
24. Potter, H., Weir, L., Leder, P., Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA 81 (1984), 7161–7165.
25. Saito, T., Sugimoto, M., Igarashi, K., Saito, K., Shao, L., Katsumi, T., Tomita, K., Sato, C., Okumoto, K., Nishise, Y., et al. Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis. Metabolism 62 (2013), 1577–1586.
26. Schuierer, S., Tranchevent, L.C., Dengler, U., Moreau, Y., Large-scale benchmark of Endeavour using MetaCore maps. Bioinformatics 26 (2010), 1922–1923.
27. Seeliger, H., Guba, M., Koehl, G.E., Doenecke, A., Steinbauer, M., Bruns, C.J., Wagner, C., Frank, E., Jauch, K.W., Geissler, E.K., Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy. Clin. Cancer Res. 10 (2004), 1843–1852.
28. Sgarrella, F., Poddie, F.P., Meloni, M.A., Sciola, L., Pippia, P., Tozzi, M.G., Channelling of deoxyribose moiety of exogenous DNA into carbohydrate metabolism: role of deoxyriboaldolase. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 117 (1997), 253–257.
29. Shimaoka, S., Matsushita, S., Nitanda, T., Matsuda, A., Nioh, T., Suenaga, T., Nishimata, Y., Akiba, S., Akiyama, S., Nishimata, H., The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma. Cancer 88 (2000), 2220–2227.
30. Sugimoto, M., Wong, D.T., Hirayama, A., Soga, T., Tomita, M., Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6 (2010), 78–95.
31. Sugimoto, M., Kawakami, M., Robert, M., Soga, T., Tomita, M., Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis. Curr. Bioinform. 7 (2012), 96–108.
32. Tabata, S., Ikeda, R., Yamamoto, M., Furukawa, T., Kuramoto, T., Takeda, Y., Yamada, K., Haraguchi, M., Nishioka, Y., Sone, S., Akiyama, S., Thymidine phosphorylase enhances reactive oxygen species generation and interleukin-8 expression in human cancer cells. Oncol. Rep. 28 (2012), 895–902.
33. Takebayashi, Y., Miyadera, K., Akiyama, S., Hokita, S., Yamada, K., Akiba, S., Yamada, Y., Sumizawa, T., Aikou, T., Expression of thymidine phosphorylase in human gastric carcinoma. Jpn. J. Cancer Res. 87 (1996), 288–295.
34. Takebayashi, Y., Yamada, K., Miyadera, K., Sumizawa, T., Furukawa, T., Kinoshita, F., Aoki, D., Okumura, H., Yamada, Y., Akiyama, S., et al. The activity and expression of thymidine phosphorylase in human solid tumours. Eur. J. Cancer 32a (1996), 1227–1232.
35. Trushina, E., Dutta, T., Persson, X.M., Mielke, M.M., Petersen, R.C., Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics. PLoS ONE, 8, 2013, e63644.
36. Uetaki, M., Tabata, S., Nakasuka, F., Soga, T., Tomita, M., Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress. Sci. Rep., 5, 2015, 13896.
37. Yang, M., Vousden, K.H., Serine and one-carbon metabolism in cancer. Nat. Rev. Cancer 16 (2016), 650–662.